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The process of recombinational repair is crucial for maintaining genomic
integrity and generating biological diversity. In association with RuvB and
RuvC, RuvA plays a central role in processing and resolving Holliday junctions,
which are a critical intermediate in homologous recombination. Here, the
cloning, purification and structure determination of the RuvA protein from
Mycobacterium tuberculosis (MtRuvA) are reported. Analysis of the structure
and comparison with other known RuvA proteins reveal an octameric state with
conserved subunit–subunit interaction surfaces, indicating the requirement of
octamer formation for biological activity. A detailed analysis of plasticity in the
RuvA molecules has led to insights into the invariant and variable regions, thus
providing a framework for understanding regional flexibility in various aspects
of RuvA function.
1. Introduction
Recombinational repair is an important cellular process responsible
for the generation of genetic diversity as well as for the maintainance
of genomic integrity. A crucial step in recombination is the resolution
of Holliday junctions produced from strand exchange between two
homologous DNA helices (Kowalczykowski et al., 1994). Branch
migration and resolution of a Holliday junction (HJ) into two
recombinant DNA helices is promoted by RuvA, RuvB and RuvC
proteins (Shinagawa & Iwasaki, 1996; West, 1996). Recombination
mechanisms have been extensively studied in Escherichia coli, but it
is unclear how far the mechanistic pathways elucidated in this species
are applicable to other organisms, such as mycobacteria (McFadden,
1996; Muniyappa et al., 2000). Extrapolations of such a model would
also have to account for both the reduced levels of homologous
recombination and the higher levels of illegitimate recombination
promoted by the tubercle bacillus.
Homologous recombination is also an important process that has
been exploited to generate desired mutants in several model organ-
isms (Muniyappa et al., 2000). In mycobacteria, however, difficulties
in defining the phenotype of both wild-type and mutant strains have
hampered genetic analysis of the organism (Shinagawa & Iwasaki,
1996). To facilitate genetic manipulation in mycobacteria, it is
important to examine the roles of each of the components in the
recombination pathway systematically. In this context, we have
previously determined and analysed the crystal structure of the RecA
protein from Mycobacterium tuberculosis (MtRecA) and M. smeg-
matis (MsRecA), a key component of the recombination machinery
involved in strand exchange (Datta et al., 2000; Datta, Ganesh et al.,
2003; Datta, Krishna et al., 2003; Krishna et al., 2006). Here, we report
the crystal structure of the RuvA protein from M. tuberculosis
(MtRuvA).
2. Materials and methods
2.1. Cloning, protein expression and purification
A 0.59 kbp DNA fragment containing the ruvA gene (Rv2593c)
was amplified by PCR from the M. tuberculosis H37Rv Cosmid
library with Pfu DNA polymerase (Stratagene), using the 50 NdeI
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primer 50-AGATATACATATGATCGCCTCGGTCCGCGGTGAG
GTG-30 and the 30 BamHI primer 50-AATTCGGATCCTCGGGCC-
TTCCCCAGCAACGACAA-30. The bases in bold represent the
NdeI and BamHI cleavage sites, respectively. The PCR amplicon was
digested with NdeI and BamHI (NEB) and isolated using a Qiaquick
PCR spin column (Qiagen). The product was ligated into a modified
pET-28 vector containing a C-terminal six-His tag in frame with the
BamHI restriction site using T4 DNA ligase (NEB) and transformed
into BL21(DE3) (Novagen). The expressed protein contained the
C-terminal tag GSHHHHHH, where GS is encoded by the BamHI
restriction site (GGATCC). A 3 ml BL21(DE3) cell culture was
tested for the expression of heterologous protein by binding to
cobalt-chelated Talon superflow bead slurry (Clontech) and SDS–
PAGE analysis.
The cells were grown as described by Studier (2005) with some
modifications. The transformed cells were inoculated into 3 ml
culture media (1 mM MgSO4, 0.5% glucose, the 17 amino acids Na–
Glu, Asp, Lys–HCl, Arg–HCl, His–HCl, Ala, Pro, Gly, Thr, Ser, Gln,
Asn, Val, Leu, Ile, Phe and Trp, each at 100 mg ml1, a metal mix of
50 mM Fe, 20 mM Ca, 10 mMMn, 10 mM Zn, 2 mM Co, Cu, Ni, Mo, Se
and B and NPS with 5 mM phosphate, 5 mM Na, 2.5 mM K, 2.5 mM
ammonium, 1.25 mM sulfate) and grown overnight at 310 K. From
the seed culture, 0.5 ml was inoculated into 500 ml auto-induction
media containing 1 mM MgSO4, a metal mix (the same as the seed
culture), 0.5% glycerol, 0.5% glucose, 0.2% -lactose, NPS (the same
as the seed culture) and 35 mg ml1 kanamycin. After the cells had
been grown at 310 K until OD600 reached 0.5, cell growth was
continued at 293 K for approximately 21 h until OD600 reached
approximately 15 (as inferred from dilutions). The cells were
harvested and stored at 193 K.
The cell pellet was lysed by sonication in 10 ml buffer A (20 mM
Tris pH 8.0, 100 mM NaCl) per gram of cells for 10 min in 30 s pulses
at 283 K. The cell debris was removed by centrifugation for 30 min at
38 000 rev min1 using a Ti-60 rotor (Beckman). The supernatant was
filtered through a 0.45 mm pore membrane and loaded onto a 5 ml
Talon superflow cobalt-affinity column equilibrated with buffer A.
After washing with 30 ml buffer A and 20 ml buffer B (20 mM Tris
pH 8.0, 100 mM NaCl, 20 mM imidazole), the His-tagged ruvA was
eluted from the column using buffer C (20 mM Tris–HCl pH 8.0,
100 mM NaCl and 300 mM imidazole). The eluted fraction was
dialyzed against buffer D (20 mM Tris pH 8.0, 100 mM NaCl, 10 mM
-mercaptoethanol) and chromatographed on a Superdex-75 column
(Amersham Biosciences) using buffer D for equilibration and
elution. The peak fractions (monitored at OD280) were analyzed by
SDS–PAGE and the pooled protein fractions were concentrated to
3 mg ml1 using a Centricon Plus-20 (Millipore). The RuvA protein
preparation, which had 97% purity as deduced by SDS–PAGE and
MALDI–TOF mass spectroscopy (Applied Biosystem), was used for
crystallization.
2.2. Crystallization and data collection
MtRuvA was crystallized at room temperature using the sitting-
drop vapour-diffusion (IntelliPlate, Robbins Instruments) technique.
Drops were made up of 0.5 ml of a 3 mg ml1 protein stock and 0.5 ml
reservoir solution. Protein stock was buffered in 20 mM Tris–HCl pH
8.0 with 100 mM sodium chloride and 10 mM -ME. The reservoir
contained 0.1M sodium succinate pH 5.5 and 1.7M ammonium
sulfate. Crystals formed in a few days and were allowed to grow larger
in size (150  150  50 mm) for up to a few months. Crystals belong
to the tetragonal space group P42212, with unit-cell parameters
a = b = 137.64, c= 88.97 A˚ and contained a single tetrameric molecule
in the asymmetric unit. Diffraction screening and data collection were
conducted on beamlines 5.0.1 and 5.0.2 at the Advanced Light Source
(ALS), Lawrence Berkeley National Laboratory. The diffraction data
were processed with the program suite HKL-2000 (Otwinowski &
Minor, 1997). Data-collection statistics are given in Table 1.
2.3. Structure solution and refinement
The structure of MtRuvA was determined by molecular replace-
ment using AMoRe (Navaza, 1994) with one of the tetramers of the
M. leprae RuvA molecule (PDB code 1bvs) as the initial search
model and was refined at 2.7 A˚ resolution using CNS (Bru¨nger et al.,
1998). The starting model was subjected to rigid-body refinement,
treating the three domains of each subunit of the protein as rigid
groups. This was followed by cycles of positional refinement and
simulated annealing. Both 2Fo  Fc and Fo  Fc electron-density
maps were generated from calculated phases based on the roughly
refined model at this stage. The atomic model was built using the
program O (Jones et al., 1991) in an iterative manner until conver-
gence of R and Rfree. The grouped B factors in main chains and side
chains for the protein residues were refined and the bulk-solvent
correction was applied. Clear electron densities exist for four glycerol
molecules. 374 O atoms were added to the model based on densities
above 2.5 and 0.8 in Fo  Fc and 2Fo  Fc maps, respectively. Of
these, those which were within 4 A˚ of any protein atom, numbering
270, were retained in the coordinate list as probable water O atoms.
The electron density corresponding to residues 133–145 and 193–195
was hardly discernible even at the final stage of refinement,
presumably owing to structural disorder. The final R and Rfree were
23.3 and 27.3, respectively. The stereochemical quality of the struc-
tures was validated using PROCHECK (Laskowski et al., 1993). The
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Table 1
X-ray crystal data, refinement and model statistics.
Values in parentheses are for the highest resolution shell (2.8–2.7 A˚).
Crystal data and data-collection statistics
Space group P42212
Unit-cell parameters
a (A˚) 137.64
c (A˚) 88.97
 =  =  () 90
Resolution range (A˚) 45.0–2.7
Matthews coefficient VM (A˚
3 Da1) 2.63
Solvent content (%) 53.2
Subunits per ASU 4
Unique reflections 23937 (2325)
Multiplicity 7.8 (7.9)
Data completeness (%) 99.9 (100)
Mean I/(I) 14.1 (2.7)
Rmerge (%)† 10.6 (51.2)
Refinement and model statistics
R factor 23.3
Rfree‡ 27.2
Total No. of atoms per ASU
Protein 5269
Water 270
Glycerol 24
R.m.s. deviations from ideal
Bonds (A˚) 0.006
Angles () 1.3
Dihedral angles () 22.8
Improper angles () 2.67
Ramachandran plot statistics (% of residues)
Core regions 86.6
Allowed regions 11.8
Generously allowed regions 1.6
Disallowed regions 0.0
† Rmerge =
P jIðkÞ  hIij=P IðkÞ, where I(k) is the kth intensity measurement of a
reflection, hIi is the average intensity value of that reflection and the summation is over
all measurements. ‡ 5% of reflections were used for the Rfree calculations.
salient results of validation along with refinement statistics are given
in Table 1. Superposition of structures was carried out using ALIGN
(Cohen, 1997). The plasticity of the molecule was calculated domain-
wise using the program ESCET (Schneider, 2002). Figures were
prepared by using the programs MOLSCRIPT (Kraulis, 1991) and
RASTER3D (Merritt & Bacon, 1997).
3. Results and discussion
Purified MtRuvA could be crystallized as single crystals, from which
diffraction data were collected and processed to 2.7 A˚. Structure
determination, carried out through molecular replacement with
MlRuvA as the search model, provided an acceptable solution,
revealing one tetramer in the asymmetric unit.
3.1. Monomer and tetramer
MtRuvA exhibits sequence identities of 76% with MlRuvA, 31%
with EcRuvA and 37% with TthRuvA (Thermus thermophilus
RuvA). Despite the lack of high sequence conservation across the
phyla, the overall structures of the protein from all these species
closely resemble one another. Each MtRuvA asymmetric unit
contains one RuvA tetramer, in which each subunit exhibits a
tripartite domain architecture, consisting of three domains with
distinct functional features (Rafferty et al., 1996, 1998; Yamada et al.,
2002; Roe et al., 1998; Nishino et al., 1998) as illustrated in Fig. 1: a
63-residue (1–63) N-terminal domain I, which comprises a six-
stranded -barrel with a Greek-key motif, mainly involved in the
tetramerization with a central fourfold axis, a 70-residue domain II
(64–133) made up of a helical bundle, consisting of five -helices
including two helix–hairpin–helix (HhH) motifs, which contributes to
DNA recognition, and a smaller 50-residue (146–196) domain III,
made up of a three-helix bundle, involved in RuvB binding. A
13-residue flexible linker connects domains II and III, the precise
functional roles are not as yet fully characterized. Each tetramer has a
non-crystallographic fourfold symmetry comparable to that observed
in all other RuvA structures. The symmetry, however, is near-perfect
when only domains I and II are considered. A considerable departure
from fourfold symmetry is exhibited by domain III, indicative of its
relative flexibility.
3.2. Octamerization
The MtRuvA tetramer in the asymmetric unit and its twofold
symmetry equivalent constitute an octamer resembling those of
MlRuvA (Roe et al., 1998) and TthRuvA (Yamada et al., 2002). Helix
117–126 from each of the four subunits of one tetramer is found to
interact with its counterpart in the second tetramer. These inter-
actions involving eight helices are primarily through salt bridges
between conserved arginine and glutamic acid residues, which have
also been noted previously in the discussion on the MlRuvA octamer
(Roe et al., 1998). A conserved hydrophobic residue, most often a
leucine, making van der Waals interactions with the same residue
from the other subunit is also found at the octamer interface. The
conserved arginine, the glutamic acid and the leucine all belong to the
HhH motif II of domain II. In addition to these, Ser78 from motif I of
domain II also appears to be within interaction distance of its
counterpart at the interface across the tetramers. This position too is
predominantly occupied by polar uncharged amino acids in other
RuvAs. A similar interaction could also be inferred from the
MlRuvA structure. Although the electrostatic interactions in the
interface are, in general, similar in the octamers of MtRuvA,
MlRuvA and TthRuvA, the tetramers are slightly farther away from
each other in TthRuvA. The distance between the centroids of the
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Figure 1
Domain architecture of the RuvA tetramer. A schematic representation of the sequence is shown in the top panel. The four subunits are labelled A, B, C and D. The three
domains in each subunit, DI, DII and DIII, are shown in subunit A. The key functional motifs are highlighted (Rafferty et al., 1996, 1998; Yamada et al., 2002; Roe et al., 1998;
Nishino et al., 1998). The residue numbers are based on the MtRuvA sequence. Variant (red) and invariant (blue) regions of the tetrameric RuvA deduced from an analysis
of MtRuvA, MlRuvA, EcRuvA and TthRuvA are illustrated.
two tetramers is 37.6, 38.2 and 40.1 A˚, respectively, in MtRuvA,
MlRuvA and TthRuvA.
3.3. Plasticity of the molecule
An appreciation of the structural flexibility within the RuvA
molecule is of great importance in order to understand its function
thoroughly. The relatively variant and invariant regions of the
molecules have been delineated employing different available crystal
structures using an error-inclusive structure comparison and evalua-
tion tool (ESCET). Two monomers from M. tuberculosis and
M. leprae, three independent monomers from E. coli, including one
from the molecule bound to DNA, and one monomer from T. ther-
mophilus were included in the calculations. Calculations were
performed independently for each domain. The cutoff parameter was
carefully chosen as 2.7 such that neither too few nor too many
residues were delineated as flexible regions, in the same manner as
has been performed by us previously in relation to the structures of
the single-stranded binding protein, ribosome recycling factor from
M. tuberculosis (Saikrishnan, Manjunath et al., 2005; Saikrishnan,
Kalapala et al., 2005) and Dps from M. smegmatis (Roy et al., 2004).
The above analysis enabled a delineation of the invariant and
variable regions in the molecule (Fig. 1). Domain I has distinct
segments of invariant and variable residues approximately divided by
the barrel axis making up the OB (oligonucleotide/oligosaccharide-
binding) fold of the domain. The N-terminal loop of domain I is
flexible, whereas the first three -strands are rigid. The helix that caps
the barrel is flexible. The last two strands in domain I are partly
flexible. The flexible regions of these strands are also involved in the
subunit–subunit interface of the tetramer. Consequently, it appears
that the intersubunit interface consists of an invariant and a variable
region, where the invariant segment of one subunit interacts with the
variable segment of the other. In the second domain, the first HhH
motif is variable, whereas the second motif is mainly invariant, with
only the rear end identified as variable. These two motifs host the
residues that are involved in the HJ binding. A significant alteration
in the subunit orientations upon DNA binding has been reported
previously for this domain (Ariyoshi et al., 2000). Domain III is
surprisingly predominantly invariant, suggesting that the movements
of the domain that accompany RuvB binding are largely rigid-body
movements.
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